Japan proposes lower generic starting prices to boost uptake
This article was originally published in Scrip
Executive Summary
The Japanese government has proposed cutting the initial reimbursement price of first-time generics to improve the uptake of such products, as part of wider ongoing drug pricing reform discussions due to be finalised by next spring.